River BioMedics Raises Seed Investment to Progress its Cardiovascular Disease Programs• Eur 1.8 million seed funding to progress its pipeline of cardiovascular disease targets• Company appoints Nicky Cooper as its Chief Executive Officer• Financing round co-led by FIRST Fund, KIKK Capital and Oost NLE...